In India, we have a legacy of over 100 years. With our new purpose, strategy and culture, we will move #AheadTogether continuing our legacy in General Medicines, our leadership in the Vaccines self-pay market and introduce innovative offerings through our Specialty medicines. ...
Want to start a career in the pharma industry? Find job opportunities in the Sales, Marketing and other departments of GSK Pharma India. Diversity, equity and inclusion We seek, value and draw on the differing knowledge, perspectives, experiences and styles resident in the larger community. ...
GSK to Up Stake in India Unit for Rs6.38K Cr: Parent to Make Open Offer at Rs3,100 per Share for 24% More in Feb; GSK Pharma Soars 19% to 52-Week HighTiwari, Ashish K
GlaxoSmithKline (GSK) Pharma, marking its 100th year in India, is shifting its focus toward becoming a specialty-driven company, with an emphasis on preventive healthcare through adult vaccines. As I...查看全文 相关企业信息 公司名称:葛兰素史克(中国)投资有限公司 法人代表:余慧明 注册资本:150976.8846...
During my last internship at a pharma company, I received critical feedback while working on a high-stakes project from my supervisor that my recent report lacked clarity and needed more detailed analysis. Task: I was tasked to implement the feedback promptly to improve my project report to en...
GSK is one of the most innovative companies operating in Poland and is of major importance for the development of the domestic pharma industry and the Polish economy as a whole. The total amount of remuneration paid to employees, including those employed at the Poznań production plant, reached ...
Our activity in 2023 included the acquisition of Bellus Health and Aiolos Bio1, which both further strengthen our respiratory pipeline, and the signing of licence agreements with Janssen and Hansoh Pharma, in infectious diseases and oncology. Upgrading our outlooks In 2024, we expect another year ...
Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison. Sumeet SinghFollow 506 Views Share bullish•Thematic (Sector/Industry...
MarketplaceFront & CenterICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers Webcasts Multimedia All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug So...
HCP detailing is obviously a core capability and competence of 31 our pharma group. They spend a number of years developing a fantastic tool that was really optimised. Last year, we basically took that off the shelf, and rolled it out across 80 markets. It wouldn't be something that ...